NCT02189941View on ClinicalTrials.gov

Pilot Study of the Pharmacokinetic Profile of Deferiprone Sustained-Release Formulation in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Healthy
Interventions
DRUG

Deferiprone sustained-release

Deferiprone sustained-release tablets

DRUG

Deferiprone immediate-release

Deferiprone immediate-release tablets

Trial Locations (1)

M9L 1P7

Apotex Inc. BioClinical Development, Toronto

Sponsors

Lead Sponsor

ApoPharma
All Listed Sponsors
lead

ApoPharma

INDUSTRY

NCT02189941 - Pilot Study of the Pharmacokinetic Profile of Deferiprone Sustained-Release Formulation in Healthy Volunteers | Biotech Hunter | Biotech Hunter